The Polish biotech company is seeking industrial and research partners interested in applying advanced 3D bioprinted tissue models and biomaterials to improve the predictive power and efficiency of preclinical research and drug development.
A Polish client is a biotechnology company operating at the intersection of tissue engineering, 3D bioprinting, and regenerative medicine. The company develops biomaterials, tissue models, and enabling technologies supporting translational medicine, drug development, and advanced therapeutic solutions. The company is seeking industrial and research partners in EEA countries, USA, India, Canada and Japan.